These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 1394697
21. Highly selective synthetic inhibitors with regard to plasma-kallikrein activities. Okamoto S, Okamoto U, Wanaka K, Hijikata-Okunomiya A, Bohgaki M, Naito T, Horie N, Okada Y. Adv Exp Med Biol; 1989; 247B():29-34. PubMed ID: 2610076 [Abstract] [Full Text] [Related]
33. [Synthesis of omega-carboxyacyl-L-phenylalanine-aryl esters and their use as substrates for cathepsin G and chymotrypsin]. Schnabel E. Hoppe Seylers Z Physiol Chem; 1981 Jun 04; 362(6):655-64. PubMed ID: 7275004 [Abstract] [Full Text] [Related]
34. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates. McRae BJ, Kurachi K, Heimark RL, Fujikawa K, Davie EW, Powers JC. Biochemistry; 1981 Dec 08; 20(25):7196-206. PubMed ID: 6976185 [Abstract] [Full Text] [Related]
38. 1-Amino-2-phenylethylphosphonic acid: an inhibitor of L-phenylalanine ammonia-lyase in vitro. Janas KM, Filipiak A, Kowalik J, Mastalerz P, Knypl JS. Acta Biochim Pol; 1985 Sep 04; 32(2):131-43. PubMed ID: 4036447 [Abstract] [Full Text] [Related]
39. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor. Takahashi H, Nagasawa S, Suzuki T. J Biochem; 1980 Jan 04; 87(1):23-34. PubMed ID: 6766924 [Abstract] [Full Text] [Related]